An Extension Study of Subcutaneous Secukinumab to Evaluate the Long-term Efficacy, Safety and Tolerability up to 4 Years in Patients With Juvenile Idiopathic Arthritis Subtypes of Juvenile Psoriatic Arthritis and Enthesitis Related Arthritis
收藏DataCite Commons2026-03-27 更新2026-05-07 收录
下载链接:
https://search.vivli.org/doiLanding/studies/PR00012941/isLanding
下载链接
链接失效反馈官方服务:
资源简介:
Optional open label, roll over extension study to investigate the efficacy and safety of secukinumab treatment in Juvenile Idiopathic Arthritis (JIA) subtypes of Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA).
提供机构:
Vivli
创建时间:
2026-03-27



